Literature DB >> 7507109

Classification of alpha 2-macroglobulin-cytokine interactions based on affinity of noncovalent association in solution under apparent equilibrium conditions.

K P Crookston1, D J Webb, B B Wolf, S L Gonias.   

Abstract

alpha 2-Macroglobulin (alpha 2M) binds numerous cytokines; however, since binding affinities have not been determined, it is difficult to compare various alpha 2M-cytokine interactions or predict whether alpha 2M-cytokine complexes will form in the presence of other cytokine-binding macromolecules. In this investigation, we used a novel method to demonstrate that transforming growth factor-beta 1 (TGF-beta 1), TGF-beta 2, nerve growth factor-beta (NGF-beta), platelet derived growth factor-BB (PDGF-BB), tumor necrosis factor-alpha (TNF-alpha), and basic fibroblast growth factor (bFGF) reversibly associate with alpha 2M-methylamine to form noncovalent complexes. Apparent equilibrium was achieved in less than 15 min. Noncovalent alpha 2M-cytokine complexes were converted into covalent complexes; however, this occurred slowly. Therefore, a rapid equilibrium assumption was applied and equilibrium dissociation constants were determined using a single binding site model. KD values for the binding of cytokines to alpha 2M-methylamine varied by 2 orders of magnitude. The rank order of affinity was TGF-beta 2 (13 +/- 2 nM) > TGF-beta 1, NGF-beta > PDGF-BB > or = bFGF > TNF-alpha. Native alpha 2M bound TGF-beta 1, TGF-beta 2, NGF-beta, PDGF-BB, and TNF-alpha. Interferon-gamma did not bind to native alpha 2M or alpha 2M-methylamine. Each cytokine bound native alpha 2M with lower affinity than alpha 2M-methylamine except for TGF-beta 2 which bound both forms with equal affinity. In non-equilibrium systems, alpha 2M-methylamine appeared to bind more TGF-beta 2 due to the more rapid dissociation of TGF-beta 2-native alpha 2M complex. The classification of alpha 2M-cytokine complexes according to binding affinity should predict which complexes are most likely to form in cell culture and under various conditions in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507109

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

Review 1.  Latent-TGF-beta: an overview.

Authors:  D A Lawrence
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Delayed wound healing in CXCR2 knockout mice.

Authors:  R M Devalaraja; L B Nanney; J Du; Q Qian; Y Yu; M N Devalaraja; A Richmond
Journal:  J Invest Dermatol       Date:  2000-08       Impact factor: 8.551

3.  alpha2-macroglobulin modulates the immunoregulatory function of the lipocalin placental protein 14.

Authors:  G J Riely; J Rachmilewitz; P H Koo; M L Tykocinski
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

4.  A 16-amino acid peptide from human alpha2-macroglobulin binds transforming growth factor-beta and platelet-derived growth factor-BB.

Authors:  D J Webb; D W Roadcap; A Dhakephalkar; S L Gonias
Journal:  Protein Sci       Date:  2000-10       Impact factor: 6.725

5.  Beta-amyloid peptide binds equivalently to binary and ternary alpha2-macroglobulin-protease complexes.

Authors:  Joseph M Mettenburg; Steven L Gonias
Journal:  Protein J       Date:  2005-02       Impact factor: 2.371

6.  Physical interaction of CCN2 with diverse growth factors involved in chondrocyte differentiation during endochondral ossification.

Authors:  Hany Mohamed Khattab; Eriko Aoyama; Satoshi Kubota; Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2015-04-19       Impact factor: 5.782

7.  Cytochrome P450 inactivation by serum from humans with a viral infection and serum from rabbits with a turpentine-induced inflammation: the role of cytokines.

Authors:  A M Bleau; M C Levitchi; H Maurice; P du Souich
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

8.  Effect of implantation of Augment(®) Bone Graft on serum concentrations of platelet-derived growth factors: a pharmacokinetic study.

Authors:  Luis A Solchaga; Timothy Daniels; Stephen Roach; William Beasley; Leo B Snel
Journal:  Clin Drug Investig       Date:  2013-02       Impact factor: 2.859

9.  Differences in the binding of transforming growth factor beta 1 to the acute-phase reactant and constitutively synthesized alpha-macroglobulins of rat.

Authors:  D J Webb; K P Crookston; N L Figler; J Lamarre; S L Gonias
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

10.  Characterization of the interaction between alpha2-macroglobulin and fibroblast growth factor-2: the role of hydrophobic interactions.

Authors:  Smitha Mathew; Sanja Arandjelovic; Wayne F Beyer; Steven L Gonias; Salvatore V Pizzo
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.